title: Dermatological side effects of intravesical Mitomycin C: Delayed hypersensitivity.
abstract: To know the dermatologic side effects of intravesical treatment with Mitomycin C in non muscle invasive bladder cancer.
  
  
  
  We describe two cases of palm and plantar dermatitis after such treatment.
  
  
  
  We describe two types of dermatitis pathogenesis during treatment with intravesical Mitomycin C: contact dermatitis and delayed hypersensitivity dermatitis.
  
  
  
  Contact dermatitis of non-allergic origin is a common side effect described in many instances in the literature, on the other hand exists dermatitis secondary to delayed hypersensitivity type IV much less common, requiring treatment with corticosteroids.
authors.affiliation: Servicio de Urología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. España.
authors.forename: A
authors.initials: A
authors.lastname: Colomer Gallardo
authors.affiliation: Servicio de Urología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. España.
authors.forename: R
authors.initials: R
authors.lastname: Martínez Rodríguez
authors.affiliation: Servicio de Urología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. España.
authors.forename: C
authors.initials: C
authors.lastname: Castillo Pacheco
authors.affiliation: Servicio de Urología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. España.
authors.forename: C
authors.initials: C
authors.lastname: González Satue
authors.affiliation: Servicio de Urología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. España.
authors.forename: L
authors.initials: L
authors.lastname: Ibarz Servio
mesh_terms: D000283:Administration, Intravesical; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D016685:Mitomycin / Q000008:administration & dosage / Q000009:adverse effects*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
chemical_list: D000903:Antibiotics, Antineoplastic; D016685:Mitomycin